Frequency of KRAS G12C plus co-mutations in solid tumors and adequate test methods

被引：0
|
作者：
Schatz, Stefanie [1 ]
Falk, Markus [1 ]
Tiemann, Markus [1 ]
机构：
[1] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
554
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [31] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Tereza Vaclova
    Atanu Chakraborty
    James Sherwood
    Sarah Ross
    Danielle Carroll
    J. Carl Barrett
    Julian Downward
    Elza C. de Bruin
    Scientific Reports, 12
  • [32] Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet plus Bevacizumab
    Giampieri, Riccardo
    Lupi, Alessio
    Ziranu, Pina
    Bittoni, Alessandro
    Pretta, Andrea
    Pecci, Federica
    Persano, Mara
    Giglio, Enrica
    Copparoni, Cecilia
    Crocetti, Sonia
    Mandolesi, Alessandra
    Faa, Gavino
    Coni, Pierpaolo
    Scartozzi, Mario
    Berardi, Rossana
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [33] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Vaclova, Tereza
    Chakraborty, Atanu
    Sherwood, James
    Ross, Sarah
    Carroll, Danielle
    Barrett, J. Carl
    Downward, Julian
    de Bruin, Elza C.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] KRAS G12C mutations in Hispanic and non-Hispanic patients with NSCLC: clinicopathologic characteristics and prognosis
    Manoharan, Aysswarya
    Kareff, Samuel A.
    Ramos, Leana M.
    El-Abbar, Nora A.
    Lopes, Gilberto
    Rodriguez, Estelamari
    CANCER RESEARCH, 2023, 83 (07)
  • [35] First-in-human study of ZG19018, targeting KRAS G12C, as monotherapy in patients with advanced solid tumors.
    Liu, Rongrui
    Qu, Xiujuan
    Yang, Nong
    Chai, Xiaoli
    Xu, Jianming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Quantifying KRAS G12C Covalent Drug Inhibitor Activity in Mouse Tumors Using Mass Spectrometry
    Tran, John C.
    Hunsaker, Thomas
    Bell, Christina
    Ma, Taylur P.
    Chan, Emily
    Larrocha, Pablo Saenz-Lopez
    Homyk, Kelsey
    Liu, Liling
    La, Hank
    Mao, Jialin
    de la Cruz, Cecile C.
    Yu, Kebing
    Beresini, Maureen
    Forrest, William F.
    Xiao, Yang
    Jang, Anne
    Samus, Natalia
    Stesco, Nicholas Dupuis
    Mentinova, Marija
    Parent, Stephane
    Pottiez, Gwenael
    Schirm, Michael
    Purkey, Hans E.
    Liu, Yichin
    Merchant, Mark
    ANALYTICAL CHEMISTRY, 2023, 95 (11) : 4834 - 4839
  • [37] Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C
    Notario, Lucia
    Cucurull, Marc
    Cerda, Gabriela
    Sanz, Carolina
    Carcereny, Enric
    Munoz-Marmol, Ana
    Hernandez, Ainhoa
    Domenech, Marta
    Moran, Teresa
    Sanchez-Cespedes, Montse
    Costa, Marta
    Mate, Jose-Luis
    Esteve, Anna
    Saigi, Maria
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
    Shahnam, Adel
    Davis, Alexander
    Brown, Lauren Julia
    Sullivan, Isaac
    Lin, Kevin
    Ng, Chien
    Yeo, Nicholas
    Kong, Benjamin Y.
    Khoo, Trisha
    Warburton, Lydia
    Da Silva, Ines Pires
    Mullally, William
    Xu, Wen
    O'Byrne, Ken
    Bray, Victoria
    Pal, Abhijit
    Mersaides, Antony
    Itchins, Malinda
    Arulananda, Surein
    Nagrial, Adnan
    Kao, Steven
    Alexander, Marliese
    Lee, Chee Khoon
    Solomon, Benjamin
    John, Thomas
    LUNG CANCER, 2025, 201
  • [39] A phase 1 study of D3S-001, a second-generation GDP-bound KRAS G12C inhibitor, as monotherapy in patients with KRAS G12C-mutated solid tumors
    Cho, Byoung Chul
    Lu, Shun
    Lee, Myung Ah
    Song, Zhengbo
    Park, John
    Lim, Sun Min
    Li, Ziming
    Zhao, Jun
    Richardson, Gary
    Zhang, Yanqiao
    Zhang, Jun
    Liu, Anwen
    Chen, Cheng
    Wang, Jia
    Lu, Jingtao
    Rui, Haopeng
    Chen, Qian
    Wang, Hui
    Zhang, Jing
    Chen, Zhi Jian
    Mok, Tony
    CANCER RESEARCH, 2024, 84 (07)
  • [40] A Phase 1B Trial of Tarloxotinib and Sotorasib in Lung Cancer Patients with KRAS G12C Mutations
    Alexander, M.
    Tirunagaru, V. G.
    Doebele, R. C.
    Wrangle, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S361 - S361
12345